Phase 3 Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children and young people who are under 18 years old at the time of joining the trial
- People who have been diagnosed with, or are suspected of having, a condition called histiocytosis, based on previous test results
- People (or their guardians) who have signed a consent form agreeing to take part in the trial, as required by current regulations
Who may not be able to join:
- People who are pregnant
- People who have other serious or ongoing health conditions, unusual behaviours, or abnormal test results that the trial doctor believes could make participation unsafe, affect the trial results, or otherwise make participation unsuitable (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Anna Raciborska, Mother and Child Institute
Phone: +48 22 32 77 205
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
EFS - (event-free survival)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.